Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Marathon Petroleum Corp (MPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Marathon Petroleum Corp — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Marathon Petroleum Corp trades at $488.17 (market cap $136.18B). The key difference: Marathon Petroleum Corp is far larger — about 4.4× GE HealthCare Technologies Inc. Common Stock's market cap, and Marathon Petroleum Corp pays the higher dividend (0.82%). Which is the better fit depends on your goals.
| GEHC | MPC | |
|---|---|---|
Market Cap | $30.93B | $136.18B |
Volume | 5,033,451 | 1,631,475 |
Sector | Health | Energy |
52-Week High | $88.16 | $484.92 |
52-Week Low | $59.48 | $162.63 |
Enterprise Value | $39.39B | $162.70B |
Dividend Yield | 0.23% | 0.82% |
Typical Hold Time | — | 53 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Marathon Petroleum (MPC) trades at $476.98, up 3.96% with strong bullish momentum. The stock demonstrates robust fundamentals with consistent earnings beats, a 47.9% ROE, and attractive valuation metrics including a 16.54 P/E ratio. Technical indicators show bullish moving averages while RSI suggests overbought conditions near resistance at $479. Recent news highlights refining margin strength amid tight global capacity.
MPC presents a compelling investment case with strong profitability and analyst support (75.8% buy ratings), though current price exceeds consensus target. Key risks include potential diesel export restrictions and cyclical refining margins. The company's cash flow recovery and dividend stability provide shareholder value support amid energy sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Marathon Petroleum Corp
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →
